You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 17, 2024

Liothyronine sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for liothyronine sodium and what is the scope of freedom to operate?

Liothyronine sodium is the generic ingredient in three branded drugs marketed by Xgen Pharms, Endo Operations, King Pharms, Biocon Pharma, Dr Reddys Labs Sa, Norvium Bioscience, Sigmapharm Labs Llc, Sun Pharm, Teva Pharms Usa, Watson Labs, and Zydus Lifesciences, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for liothyronine sodium. Twenty-one suppliers are listed for this compound.

Summary for liothyronine sodium
US Patents:0
Tradenames:3
Applicants:11
NDAs:12
Drug Master File Entries: 4
Finished Product Suppliers / Packagers: 21
Raw Ingredient (Bulk) Api Vendors: 76
Clinical Trials: 15
Patent Applications: 1,932
What excipients (inactive ingredients) are in liothyronine sodium?liothyronine sodium excipients list
DailyMed Link:liothyronine sodium at DailyMed
Recent Clinical Trials for liothyronine sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Minnesota - Clinical and Translational Science InstitutePhase 1/Phase 2
University of MinnesotaPhase 1/Phase 2
Aultman Health FoundationPhase 2

See all liothyronine sodium clinical trials

Pharmacology for liothyronine sodium
Drug Classl-Triiodothyronine

US Patents and Regulatory Information for liothyronine sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 091382-001 Apr 20, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 211510-002 Oct 26, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sigmapharm Labs Llc LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 200295-003 Nov 29, 2012 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 085753-001 Feb 3, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Lifesciences LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 214803-002 Jan 22, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.